Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Richard Davis
End-stage renal disease can best be treated with kidney transplantation. The main drawback of this strategy right now is the disparity between the number of people on a transplant list and the number of organs available. Kidneys from older patients have been used to expand the pool of organs that can be transplanted. However, graft small renal tumors are more likely to occur when these organs are combined with prolonged immunosuppressive treatment. The purpose of this narrative review is to present the most recent findings regarding the clinical impact and treatment of small renal tumors that have been discovered by accident in either recipients or donors. The most recent evidence suggests that high-risk hemodialysis patients may benefit from using grafts with a small renal mass following bench table tumor excision. On the other hand, a conservative treatment to preserve renal function should be possible if a small renal mass is discovered early during periodic ultrasound examination of the graft. Finally, a radical nephrectomy is typically recommended for native kidney renal tumors.